MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$85,412K
Short-term marketable
securities
$51,440K
Prepaid expenses and
other current assets
$5,170K
Total fixed assets
$2,515K
Total current assets
$142,022K
Operating lease
right-of-use assets
$2,069K
Property and equipment,
net
$622K
Restricted cash
$606K
Other assets
$523K
Less accumulated
depreciation
$1,893K
Total assets
$145,842K
Total liabilities and
stockholders' equity
$145,842K
Total stockholders'
equity
$78,085K
Total liabilities
$67,757K
Accumulated deficit
-$434,831K
Additional paid-in capital
$512,779K
Total current
liabilities
$64,795K
Operating lease
liabilities
$2,962K
Common stock, 0.001 par
value per share...
$83K
Accumulated other
comprehensive gain
$54K
Accrued expenses
$58,474K
Accounts payable
$5,216K
Operating lease
liabilities, current
$1,105K
Back
Back
Balance Sheet
source: myfinsight.com
Larimar Therapeutics, Inc. (LRMR)
Larimar Therapeutics, Inc. (LRMR)